SofWave Medical Ltd. engages in the development, production, marketing, and distribution of non-invasive medical technology for skin firming and rejuvenation, tissue renewal, treatment of muscle, aging, and other physiological change in Israel, the United States, Europe, Southeast Asia, the Middle East, and internationally. The company offers an ultrasound technology that induces coagulation and subsequent revitalization for regenerated skin under the SUPERB brand; and non-invasive muscle toning technology under the Pure Impact VIP brand. It serves plastic surgeons, dermatologists, and other physicians who perform aesthetic treatments on patients. It also provides technical and clinical product support services. The company was incorporated in 2015 and is based in Yokneam Illit, Israel.
Metrics to compare | SOFW | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSOFWPeersSector | |
|---|---|---|---|---|
P/E Ratio | 86.4x | −1.4x | −0.4x | |
PEG Ratio | 0.42 | −0.09 | 0.00 | |
Price/Book | 14.5x | 3.1x | 2.6x | |
Price / LTM Sales | 5.4x | 8.4x | 3.2x | |
Upside (Analyst Target) | - | 63.4% | 50.6% | |
Fair Value Upside | Unlock | 33.9% | 6.6% | Unlock |